Serologic Hepatitis B Immunity in Vaccinated Health Care Workers
American Journal of Life Sciences
Volume 3, Issue 3, June 2015, Pages: 162-166
Received: Jan. 23, 2015; Accepted: Feb. 6, 2015; Published: May 12, 2015
Views 3557      Downloads 96
Authors
Vijaya Doddaiah, Department of Microbiology, Adichunchanagiri Institute of Medical Sciences, B. G. Nagara, Karnataka, India
Katta Janakiram, Department of Microbiology, Adichunchanagiri Institute of Medical Sciences, B. G. Nagara, Karnataka, India
Shakthi Ramamurthy, Department of Microbiology, Adichunchanagiri Institute of Medical Sciences, B. G. Nagara, Karnataka, IndiaDepartment of Microbiology, Adichunchanagiri Institute of Medical Sciences, B. G. Nagara, Karnataka, India
Megha Sharathchandru, Department of Microbiology, Adichunchanagiri Institute of Medical Sciences, B. G. Nagara, Karnataka, India
Yashaswini M Krishnamurthy, Department of Microbiology, Adichunchanagiri Institute of Medical Sciences, B. G. Nagara, Karnataka, India
Santhya Seenivasen, Department of Microbiology, Adichunchanagiri Institute of Medical Sciences, B. G. Nagara, Karnataka, India
Article Tools
Follow on us
Abstract
The risk of acquiring hepatitis B infection through exposure for blood or its product is highest among health care workers. The most important approach for the prevention of occupational HBV infection is the use of hepatitis B vaccine among HCWs at risk. The present study was undertaken to assess the immune status of HBV vaccinated health care workers. A total of 268 HCWs of Adichunchanagiri Hospital and Research Centre attached to AIMS, B.G.Nagara were enrolled for the study .The study group includes doctors (113), medical & nursing students (61), nurses (59), technicians (15), group D workers (12) and others (8). The serum samples of the participants were tested for Anti-HBsAb levels using ELISA kit (Diasorin, Italy). Anti HBsAb titre of ≥ 10mIU/ml was considered as immune and < 10 mIU /ml as non-immune. The mean age of the study group was 29.49 years. Of the 268 participants 54.85% were female and 45.14% male. 23.5% had history of complete vaccination and 76.49% had incomplete vaccination (1/2 doses). 72.01% were immune and 27.98% non immune. There is a need for stringent and clear policies for HBV screening, vaccination and post vaccination assessment.
Keywords
Health Care Workers, HBV Vaccine, Anti HBsAb
To cite this article
Vijaya Doddaiah, Katta Janakiram, Shakthi Ramamurthy, Megha Sharathchandru, Yashaswini M Krishnamurthy, Santhya Seenivasen, Serologic Hepatitis B Immunity in Vaccinated Health Care Workers, American Journal of Life Sciences. Vol. 3, No. 3, 2015, pp. 162-166. doi: 10.11648/j.ajls.20150303.16
References
[1]
Singhal V, Bora D, Singh S. Hepatitis B in Health care workers: Indian Scenario.J Lab Physicians2009; 1(2):41-8.
[2]
Keating GM, Noble S. Recombinant hepatitis B vaccine (Energix-B): A review of its immunogenicity and protective efficacy against hepatitis B. Drugs2003; 63:1021-51.
[3]
Poland GA, Jacobson RM. Clinical practice: Prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med2004; 351:2832-8.
[4]
Barash C, Conn IM, Dimarino AJ, Marzano J, Allen ML. Serologic Hepatitis B immunity in Vaccinated Health care workers. Arch Intern Med1999; 159(13):1481-3.
[5]
Lavanchy D. Hepatits B virus epidemiology, disease burden, treatment and current and emerging prevention and control measures.J Viral Hepatitis2004; 11:97-107.
[6]
Vijaya D, Janakiram K, Sathish J. Seroprevalence of Hepatitis B virus and Hepatitis C virus in healthcare workers-AIMS,B G Nagara.American Journal of Life Sciences2013;1(4):145-9.
[7]
Jha AK, Chadha S, Bhalla P, Saini S.Hepatitis B infection in microbiology laboratory workers: prevalence, vaccination, and immunity status. Hepat Res Treat2012; 520362-6.
[8]
Chathuranga LS, Noordeen F, Abeykoon AMSB. Immune response to hepatitis B vaccine in a group of health care workers in SriLanka.Int J Infect Dis2013; 17:1078-9.
[9]
Singh G, Singh MP,Walia I, Sarin C, Ratho RK.Screening for hepatitis B and C viral markers among nursing students in a tertiary care hospital. Indian J Med Microbiol2010; 28:78-9.
[10]
Njemanze C, Erhabor O. Hepatitis B immunity status of healthcare workers in Lagos, Nigeria. Int J Biol Chem Sci2009; 3(6):1509-14.
[11]
Ganczak M. A cross-sectional study in anti hepatitis B immune status in vaccinated healthcare workers in the west Pomeranian region of Poland. Hepat Mon2012; 12(3):185-9.
[12]
Hedge S, Praveen BN, Pal S, Shetty SR, Ajila V, Babu S, Harini K. Serum antibody analysis following Hepatits B vaccination for occupational risk assessment among dental students.Nitte Univ J Health Sci2014;4(1):52-6.
[13]
Puro V, de Carli G, Cicalini S, Soldani F, PAslslev U, Begovac J,et al. European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus. Euro Surveil2005; 10:260-4.
[14]
Kubba Ak, Taylor P.Graneek B, Strobel S.Non-responders to hepatitis B vaccination:A review. Commun Dis Public Health 2003; 6:106-12.
[15]
Noh KW, Poland GA, Murray JA. Hepatitis B vaccine non-response and celiac disease. Am J Gastroentrol2003; 98:2289-92.
[16]
Shin BM, Yoo HM, Lee AS, Park SK. Seroprevalance of Hepatitis B virus among Health care workers in Korea. J Korean Med Sci 2006; 21:58-62.
[17]
Sukirti, Pati NT, Sethi A, Agrawal K, Agrawal K, Kumar GT, Kumar M, Kaanan AT, Sarin SK. Low levels of awareness, vaccine overage and the need for boosters among health care workers in tertiary care hospitals in India. J Gastroenterol Hepatol2008; 23(11):1710-5.
[18]
Azodo CC, Ehizele AO, Uche I, Erhabor P. Hepatits B Vaccination status among dental surgeons in Benin city, Nigeria. Ann Med Health Sci Res2012; 2(1):24-8.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186